Pre-commercial biotech companies with large market caps in the U.S. 2017
This statistic depicts the market capitalization of pre-commercial biotechnology companies in the United States that have reached over one billion U.S. dollars as of March 2017. At this time, Puma Biotechnology had a market capitalization of 1.38 billion U.S. dollars.